We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Shares Latest Thinking on Electronic Systems, Signatures and Records in Trials
FDA Shares Latest Thinking on Electronic Systems, Signatures and Records in Trials
The FDA offers recommendations for using electronic systems, records and signatures in clinical trials, including advice on validation, in a draft guidance released Wednesday.